{"transactions":[{"id":816293,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-03T20:06:54.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":214400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Fifth Amended and Restated Non-Employee Director Compensation Program. The Stock Option will vest over three years: 33 1/3 % of the options will vest on the first anniversary of the grant date and the remaining 66 2/3 % will vest ratably on the first day of each calendar quarter thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":214400,"derivative":{"exercise_price":1.41,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":214400},"source":{"system":"sec-edgar","filing":"0001635046-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000163504626000005/primarydocument.xml","form_type":"4"}},{"id":1862239,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:29:53.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17643,"derivative":{"exercise_price":1.09,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17643},"source":{"system":"sec-edgar","filing":"0001127602-23-018287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760223018287/form4.xml","form_type":"4"}},{"id":2235874,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:40:40.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760222017244/form4.xml","form_type":"4"}},{"id":2235873,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:40:40.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760222017244/form4.xml","form_type":"4"}},{"id":2272025,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-05-13T22:13:27.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":10756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Dr. Vickers' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":10756,"derivative":{"exercise_price":18.12,"expiration_date":"2032-05-03","underlying":"Common Stock","underlying_shares":10756},"source":{"system":"sec-edgar","filing":"0001479290-22-000068","document":"wf-form4a_165247995336599.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929022000068/wf-form4a_165247995336599.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2279311,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-05-06T22:20:01.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":11343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":11343,"derivative":{"exercise_price":18.12,"expiration_date":"2032-05-03","underlying":"Common Stock","underlying_shares":11343},"source":{"system":"sec-edgar","filing":"0001479290-22-000064","document":"wf-form4_165187558274170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929022000064/wf-form4_165187558274170.xml","form_type":"4"}},{"id":2279310,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T22:20:01.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":6059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 4, 2023, subject to Dr. Vickers' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":29722,"source":{"system":"sec-edgar","filing":"0001479290-22-000064","document":"wf-form4_165187558274170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929022000064/wf-form4_165187558274170.xml","form_type":"4"}},{"id":2638070,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-08T20:21:41.000Z","date":"2021-07-07","kind":"purchase","acquired":true,"shares":4800,"price":8.35,"value":40080.0,"ownership":{"direct":true},"balance_after":4800,"source":{"system":"sec-edgar","filing":"0001127602-21-021729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760221021729/form4.xml","form_type":"4"}},{"id":2670171,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:51:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":17438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 10, 2022 or the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17438,"derivative":{"exercise_price":9.63,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17438},"source":{"system":"sec-edgar","filing":"0001127602-21-019828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760221019828/form4.xml","form_type":"4"}},{"id":2723157,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-05-07T23:15:29.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":7551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 5, 2022, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":7551,"derivative":{"exercise_price":27.91,"expiration_date":"2031-05-04","underlying":"Common Stock","underlying_shares":7551},"source":{"system":"sec-edgar","filing":"0001479290-21-000116","document":"wf-form4_162042929549963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929021000116/wf-form4_162042929549963.xml","form_type":"4"}},{"id":2723156,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T23:15:29.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":4013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 5, 2022, subject to Dr. Vickers' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":23663,"source":{"system":"sec-edgar","filing":"0001479290-21-000116","document":"wf-form4_162042929549963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929021000116/wf-form4_162042929549963.xml","form_type":"4"}},{"id":3120386,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T21:09:19.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 4, 2021 or the date of the Issuer's 2021 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":21.91,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001127602-20-019015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000112760220019015/form4.xml","form_type":"4"}},{"id":3147282,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-05-15T22:42:24.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":19.4,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001479290-20-000069","document":"wf-form4_158958252468820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929020000069/wf-form4_158958252468820.xml","form_type":"4"}},{"id":3147281,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T22:42:24.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Dr. Vickers' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":19650,"source":{"system":"sec-edgar","filing":"0001479290-20-000069","document":"wf-form4_158958252468820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929020000069/wf-form4_158958252468820.xml","form_type":"4"}},{"id":3491387,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T21:14:17.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 11, 2020 or the date of the Issuer's 2020 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":9675,"derivative":{"exercise_price":13.6,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0000899243-19-016860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000089924319016860/doc4.xml","form_type":"4"}},{"id":3531602,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-05-11T01:11:40.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 9, 2020, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":9000,"derivative":{"exercise_price":12.82,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001479290-19-000062","document":"wf-form4_155753708535400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929019000062/wf-form4_155753708535400.xml","form_type":"4"}},{"id":3531601,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-11T01:11:40.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 9, 2020, subject to Dr. Vickers' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":13650,"source":{"system":"sec-edgar","filing":"0001479290-19-000062","document":"wf-form4_155753708535400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929019000062/wf-form4_155753708535400.xml","form_type":"4"}},{"id":3699087,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-09T21:23:44.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":18743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in 36 equal monthly installments over a three year period following January 7, 2019."}],"balance_after":18743,"derivative":{"exercise_price":15.78,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":18743},"source":{"system":"sec-edgar","filing":"0000899243-19-000842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000089924319000842/doc4.xml","form_type":"4"}},{"id":3937122,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-05-12T00:31:53.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 10, 2019, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":6000,"derivative":{"exercise_price":29.15,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001479290-18-000081","document":"wf-form4_152608509908794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929018000081/wf-form4_152608509908794.xml","form_type":"4"}},{"id":3937121,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-12T00:31:53.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 10, 2019, subject to Dr. Vickers' Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":9150,"source":{"system":"sec-edgar","filing":"0001479290-18-000081","document":"wf-form4_152608509908794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929018000081/wf-form4_152608509908794.xml","form_type":"4"}},{"id":3992604,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-17T00:05:54.000Z","date":"2018-03-16","kind":"purchase","acquired":true,"shares":900,"price":31.2,"value":28080.0,"ownership":{"direct":true},"balance_after":6150,"source":{"system":"sec-edgar","filing":"0001479290-18-000052","document":"wf-form4_152124512506409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929018000052/wf-form4_152124512506409.xml","form_type":"4"}},{"id":3992603,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-17T00:05:54.000Z","date":"2018-03-16","kind":"purchase","acquired":true,"shares":2250,"price":31.25,"value":70312.5,"ownership":{"direct":true},"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001479290-18-000052","document":"wf-form4_152124512506409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000147929018000052/wf-form4_152124512506409.xml","form_type":"4"}},{"id":4322761,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-12T23:50:30.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary,  May 11, 2018, subject to Dr. Vickers' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Compensation Policy."}],"balance_after":6000,"derivative":{"exercise_price":20.9,"expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-032209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000120919117032209/doc4.xml","form_type":"4"}},{"id":4322760,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":53832,"kind":"person","name":"Vickers Philip J.","position":1,"cik":"0001635046","reported_name":"Vickers Philip J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-12T23:50:30.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 11, 2018, subject to the Dr. Vickers' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-17-032209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635046/000120919117032209/doc4.xml","form_type":"4"}}]}